中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

重症酒精性肝炎与慢加急性肝衰竭

孙福荣 王炳元

引用本文:
Citation:

重症酒精性肝炎与慢加急性肝衰竭

DOI: 10.3969/j.issn.1001-5256.2019.03.008
详细信息
  • 中图分类号: R575.1;R575.3

Severe alcoholic hepatitis and acute-on-chronic liver failure

  • 摘要:

    酒精性肝炎(AH)患者出现以快速进展或加重的黄疸、凝血异常及肝脏相关并发症等为主的表现,往往提示发生重症AH的可能。在感染、大量饮酒等诱因的作用下,部分患者短期内病情迅速进展,不仅导致肝功能急性失代偿,并且出现以器官功能衰竭和较高的28 d病死率等为主要特征的慢加急性肝衰竭(ACLF)。早期识别ACLF并予以有效干预能够改善预后。肠道屏障功能障碍与肝-肠轴失衡在重症AH和ACLF的发展中发挥重要作用。应积极改善患者的营养状态,但药物治疗对改善ACLF病情和预后的作用有限。早期肝移植能够为患者带来更多获益。

     

  • [1] SINGAL AK, BATALLER R, AHN J, et al. ACG clinical guide-line:Alcoholic liver disease[J]. Am J Gastroenterol, 2018, 113 (2) :175-194.
    [2] GUSTOT T, JALAN R. Acute-on-chronic liver failure in pa-tients with alcohol-related liver disease[J]. J Hepatol, 2019, 70 (2) :319-327.
    [3] JEONG JH, PARK IS, KIM DH, et al. CLIF-SOFA score andSIRS are independent prognostic factors in patients with hepat-ic encephalopathy due to alcoholic liver cirrhosis[J]. Medi-cine, 2016, 95 (26) :e3935.
    [4] MOREAU R, JALAN R, GINES P, et al. Acute-on-chronicliver failure is a distinct syndrome that develops in patients withacute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144 (7) :1426-1437.
    [5] SARIN SK, KEDARISETTY CK, ABBAS Z, et al. Acute-on-chronic liver failure:Consensus recommendations of the AsianPacific Association for the Study of the Liver (APASL) 2014[J]. Hepatol Int, 2014, 8 (4) :453-471.
    [6] SARIN SK, KUMAR A, ALMEIDA JA, et al. Acute-on-chro-nic liver failure:Consensus recommendations of the Asian Pa-cific Association for the study of the liver (APASL) [J]. Hepa-tol Int, 2009, 3 (1) :269-282.
    [7] WEICHSELBAUM L, GUSTOT T. The organs in acute-on-chronic liver failure[J]. Semin Liver Dis, 2016, 36 (2) :174-180.
    [8] SZABO G. More than meets the eye:Severe alcoholic hepati-tis can present as acute-on-chronic liver failure[J]. J Hep-atol, 2018, 69 (2) :269-271.
    [9] SERSTE T, CORNILLIE A, NJIMI H, et al. The prognostic val-ue of acute-on-chronic liver failure during the course of se-vere alcoholic hepatitis[J]. J Hepatol, 2018, 69 (2) :318-324.
    [10] LEE M, LEE JH, OH S, et al. CLIF-SOFA scoring system ac-curately predicts short-term mortality in acutely decompen-sated patients with alcoholic cirrhosis:A retrospective analysis[J]. Liver Int, 2015, 35 (1) :46-57.
    [11] DHIMAN RK, AGRAWAL S, GUPTA T, et al. Chronic liver fail-ure-sequential organ failure assessment is better than the A-sia-Pacific Association for the Study of Liver criteria for defi-ning acute-on-chronic liver failure and predicting outcome[J]. World J Gastroenterol, 2014, 20 (40) :14934-14941.
    [12] YELURU A, CUTHBERT JA, CASEY L, et al. Alcoholic hepati-tis:Risk factors, pathogenesis, and approach to treatment[J]. Alcohol Clin Exp Res, 2016, 40 (2) :246-255.
    [13] LI XJ, MU Y, QIN QF, et al. Chronic high-dosage fish oilexacerbates gut-liver axis injury in alcoholic steatohepatitisin mice:The roles of endotoxin and IL-4 in Kupffer cell po-larization imbalance[J]. Toxicol Res (Camb) , 2017, 6 (5) :611-620.
    [14] ELAMIN EE, MASCLEE AA, DEKKER J, et al. Ethanol metab-olism and its effects on the intestinal epithelial barrier[J]. NutrRev, 2013, 71 (7) :483-499.
    [15] CHO YE, YU LR, ABDELMEGEED M, et al. Apoptosis of en-terocytes and nitration of junctional complex proteins promotealcohol-induced gut leakiness and liver injury[J]. J Hepatol, 2018, 69 (1) :142-153.
    [16] SHAO T, ZHAO C, LI F, et al. Intestinal HIF-1αdeletion ex-acerbates alcoholic liver disease by inducing intestinal dysbio-sis and barrier dysfunction[J]. J Hepatol, 2018, 69 (4) :886-895.
    [17] CHEN Y, GUO J, QIAN G, et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality[J].J Gastroenterol Hepatol, 2015, 30 (9) :1429-1437.
    [18] YANG AM, INAMINE T, HOCHRATH K, et al. Intestinal fungicontribute to development of alcoholic liver disease[J]. J ClinInvest, 2017, 127 (7) :2829-2841.
    [19] LALEMAN W, CLARIA J, van der MERWE S, et al. Systemicinflammation and acute-on-chronic liver failure:Too much, not enough[J]. Can J Gastroenterol Hepatol, 2018, 2018:1027152.
    [20] NEAL MD, LEAPHART C, LEVY R, et al. Enterocyte TLR4 me-diates phagocytosis and translocation of bacteria across theintestinal barrier[J]. J Immunol, 2006, 176 (5) :3070-3079.
    [21] SZABO G, PETRASEK J. Inflammasome activation and func-tion in liver disease[J]. Nat Rev Gastroenterol Hepatol, 2015, 12 (7) :387-400.
    [22] PANDEY S, KAWAI T, AKIRA S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors[J]. ColdSpring Harb Perspect Biol, 2014, 7 (1) :a016246.
    [23] GAVIN E, DAVID W. Pathogenesis of alcoholic liver disease[M]. USA:Springer, 2016:41-69.
    [24] KONO H, ROCK KL. How dying cells alert the immune systemto danger[J]. Nat Rev Immunol, 2008, 8 (4) :279-289.
    [25] WEISKIRCHEN R, TACKE F. Cellular and molecular functionsof hepatic stellate cells in inflammatory responses and liver im-munology[J]. Hepatobiliary Surg Nutr, 2014, 3 (6) :344-363.
    [26] KIM HY, KIM CW, KIM TY, et al. Assessment of scoring sys-tems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis[J]. World JGastroenterol, 2016, 22 (41) :9205-9213.
    [27] GUSTOT T, FERNANDEZ J, GARCIA E, et al. Clinical courseof acute-on-chronic liver failure syndrome and effects onprognosis[J]. Hepatology, 2015, 62 (1) :243-252.
    [28] CARR RM, CORRENTI J. Insulin resistance in clinical and ex-perimental alcoholic liver disease[J]. Ann N Y Acad Sci, 2015, 1353:1-20.
    [29] KERWIN AJ, NUSSBAUM MS. Adjuvant nutrition managementof patients with liver failure, including transplant[J]. Surg ClinNorth Am, 2011, 91 (3) :565-578.
    [30] HIGUERA-de la TIJERA F, SERVIN-CAAMANO A, SERVIN-ABAD L, et al. Malnutrition is a key prognostic factor relatedto high mortality-rate in patients with severe alcoholic hepati-tis[J]. Nutr Hosp, 2018, 35 (3) :677-682.
    [31] MITCHELL MC, FRIEDMAN LS, MCCLAIN CJ. Medical man-agement of severe alcoholic hepatitis:Expert review from theclinical practice updates committee of the AGA institute[J].Clin Gastroenterol Hepatol, 2017, 15 (1) :5-12.
    [32] THURSZ MR, RICHARDSON P, ALLISON M, et al. Predniso-lone or pentoxifylline for alcoholic hepatitis[J]. N Engl J Med, 2015, 372 (17) :1619-1628.
    [33] LOUVET A, WARTEL F, CASTEL H, et al. Infection in patientswith severe alcoholic hepatitis treated with steroids:Early re-sponse to therapy is the key factor[J]. Gastroenterology, 2009, 137 (2) :541-548.
    [34] MATHURIN P, O'GRADY J, CARITHERS RL, et al. Cortico-steroids improve short-term survival in patients with severe al-coholic hepatitis:Meta-analysis of individual patient data[J]. Gut, 2011, 60 (2) :255-260.
    [35] GARCIA-SAENZ-DE-SICILIA M, DUVOOR C, ALTAMIRA-NO J, et al. A day-4 Lille model predicts response to cortico-steroids and mortality in severe alcoholic hepatitis[J]. Am JGastroenterol, 2017, 112 (2) :306-315.
    [36] LEE BP, CHEN PH, HAUGEN C, et al. Three-year results ofa pilot program in early liver transplantation for severe alcoholichepatitis[J]. Ann Surg, 2017, 265 (1) :20-29.
    [37] WEEKS SR, SUN Z, MCCAUL ME, et al. Liver transplantationfor severe alcoholic hepatitis, updated lessons from the world'slargest series[J]. J Am Coll Surg, 2018, 226 (4) :549-557.
  • 加载中
计量
  • 文章访问数:  1416
  • HTML全文浏览量:  28
  • PDF下载量:  384
  • 被引次数: 0
出版历程
  • 出版日期:  2019-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回